TMPRSS2 and prostate carcinoma: Hi-C studies across both TMPRSS2–ERG fusion-negative and fusion-positive prostate cancer cell lines reported increased contact frequency in the region between TMPRSS2 and ERG compared to benign prostate cell lines55.